CHEMOCENTRYX INC
CHEMOCENTRYX INC
Share · US16383L1061 · CCXI · A0NBM2 (XNAS)
Overview Financial Indicators
No Price
n/a

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
- - - - 0,00 % 0,00 % -13,34 %

Company Profile for CHEMOCENTRYX INC Share

ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil cytoplasmic autoantibody-associated vasculitis. The company also develops TAVNEOS for the treatment of patients with severe hidradenitis suppurativa, as well as patients with complement 3 glomerulopathy, and lupus nephritis. In addition, it develops CCX559, an orally administered inhibitor for programmed death protein 1/programmed death-ligand 1 for the treatment of various cancers; and CCX507, an orally administered inhibitor of the chemokine receptor known as CCR9, which has completed Phase I clinical trial for the treatment of inflammatory bowel disease. Further, the company has early-stage drug candidates that targets Th17 driven diseases and CCR6. ChemoCentryx, Inc. was incorporated in 1996 and is headquartered in San Carlos, California. As of October 20, 2022, ChemoCentryx, Inc. operates as a subsidiary of Amgen Inc.

Invested Funds

The following funds have invested in: CHEMOCENTRYX INC invested:

Fund
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Vol. in million
39,09
Percentage (%)
0,09 %

Company Data

Name CHEMOCENTRYX INC
Company ChemoCentryx, Inc.
Symbol CCXI
Website https://www.chemocentryx.com
Primary Exchange XNAS NASDAQ
WKN A0NBM2
ISIN US16383L1061
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Dr. Thomas Schall
Country United States of America
Currency USD
Employees 0,2 T
Address 850 Maude Ave, 94070 Mountain View
IPO Date 2012-02-08

Ticker Symbols

Name Symbol
NASDAQ CCXI

More Shares

Investors who CHEMOCENTRYX INC hold also have the following shares in their portfolio:
ALIGN TECHNOLOGIESLOGY INC
ALIGN TECHNOLOGIESLOGY INC Share
AMGEN INC
AMGEN INC Share
APPLE INC
APPLE INC Share
AUTODESK INC
AUTODESK INC Share
BANKWELL FINANCIAL GROUP INC
BANKWELL FINANCIAL GROUP INC Share
CADENCE DESIGN SYSTEMS INC
CADENCE DESIGN SYSTEMS INC Share
CISCO SYSTEMS INC
CISCO SYSTEMS INC Share
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Share
GS FDS-G.S.EUR.CO.EQ.R EO
GS FDS-G.S.EUR.CO.EQ.R EO Fund
HSBC BANK PLC NTS LKD EUKAIROS PRF SHS 1025 22/04/24
HSBC BANK PLC NTS LKD EUKAIROS PRF SHS 1025 22/04/24 Bond
INTEL CORP
INTEL CORP Share
MICROSOFT CORP
MICROSOFT CORP Share
SCION TECH GROWTH II - WARRANTS
SCION TECH GROWTH II - WARRANTS Share
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025